Literature DB >> 30283712

Perception of Pulmonary Function in Children with Asthma and Cystic Fibrosis.

Erick Forno1,2, Neethu Abraham1, Daniel G Winger3, Christian Rosas-Salazar4, Geoffrey Kurland1,2, Daniel J Weiner1,2.   

Abstract

Background: Under-perception of pulmonary dysfunction may delay appropriate treatment, while over-perception may result in unnecessary treatments.
Objectives: To evaluate the ability of patients with asthma or cystic fibrosis and their subspecialty caregivers to assess changes in lung function based on their subjective clinical impressions.
Methods: Patients were asked to qualitatively describe how they felt compared to their prior visit (same/better/worse) and to quantitatively estimate their forced expiratory volume in 1 s (FEV1) after being reminded of their FEV1 at the prior visit. Providers made similar estimates based on history and physical examination and knowledge of prior FEV1. After adjusting for relevant clinical covariates, lung function estimates were categorized as accurate (±5% of measured FEV1), overestimated (>5% above measured), and underestimated (>5% below measured).
Results: One hundred nine patients estimated FEV1 on 179 occasions. Concordance between patient qualitative assessment and FEV1-based categories was low (κ = 0.08); 44% of patients reported feeling better than the FEV1-based category showed. Quantitatively, 56% of patient estimates were accurate, 18% were underestimated, and 26% overestimated; accuracy improved with age (odds ratio = 1.16, P = 0.01). Concordance between provider qualitative assessments and FEV1-based category was moderate (κ = 0.35); about 19% said their patient looked better than the FEV1-based category showed. Quantitatively, 65% of provider estimates were accurate, 16% were underestimated, and 19% were overestimated; accuracy improved with years of experience. Conclusions: Patients' and providers' perceptions of lung function were low to moderately accurate. Relying on subjective impression may place patients at risk for unnecessary treatments or increased morbidity. These findings highlight the importance of objective lung function assessment.

Entities:  

Keywords:  asthma; cystic fibrosis; lung function; lung function perception

Year:  2018        PMID: 30283712      PMCID: PMC6154438          DOI: 10.1089/ped.2018.0906

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol Pulmonol        ISSN: 2151-321X            Impact factor:   1.349


  22 in total

1.  Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999.

Authors:  R O Crapo; R Casaburi; A L Coates; P L Enright; J L Hankinson; C G Irvin; N R MacIntyre; R T McKay; J S Wanger; S D Anderson; D W Cockcroft; J E Fish; P J Sterk
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

2.  Method for manipulating peak flow measurements producing falsely raised readings.

Authors:  S Ross; D P Cochran
Journal:  Thorax       Date:  2001-06       Impact factor: 9.139

3.  Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR.

Authors:  Claire E Wainwright; J Stuart Elborn; Bonnie W Ramsey
Journal:  N Engl J Med       Date:  2015-10-29       Impact factor: 91.245

4.  Potential problems in peak expiratory flow data used to diagnose occupational asthma.

Authors:  M R Miller
Journal:  Occup Med (Lond)       Date:  1996-06       Impact factor: 1.611

5.  Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.

Authors:  N Lechtzin; N West; S Allgood; E Wilhelm; U Khan; N Mayer-Hamblett; M L Aitken; B W Ramsey; M P Boyle; P J Mogayzel; C H Goss
Journal:  Contemp Clin Trials       Date:  2013-09-19       Impact factor: 2.226

6.  Patterns of medical practice in cystic fibrosis: part I. Evaluation and monitoring of health status of patients. Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis.

Authors:  M W Konstan; S M Butler; D V Schidlow; W J Morgan; J R Julius; C A Johnson
Journal:  Pediatr Pulmonol       Date:  1999-10

7.  Health perceptions and treatment adherence in adults with cystic fibrosis.

Authors:  J Abbott; M Dodd; A K Webb
Journal:  Thorax       Date:  1996-12       Impact factor: 9.139

8.  Perception of pulmonary function and asthma control: the differential role of child versus caregiver anxiety and depression.

Authors:  Jonathan M Feldman; Dara Steinberg; Haley Kutner; Nina Eisenberg; Kate Hottinger; Kimberly Sidora-Arcoleo; Karen Warman; Denise Serebrisky
Journal:  J Pediatr Psychol       Date:  2013-07-19

9.  Different perceptions of disease severity and self care between patients with cystic fibrosis, their close companions, and physician.

Authors:  J Abbott; M Dodd; A K Webb
Journal:  Thorax       Date:  1995-07       Impact factor: 9.139

10.  Dyspnea perception in cystic fibrosis patients.

Authors:  B Ziegler; A K Fernandes; P R S Sanches; D P Silva Junior; P R O Thomé; P T R Dalcin
Journal:  Braz J Med Biol Res       Date:  2013-09-24       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.